Worth Venture Partners’s CryoPort CYRX Stock Holding History

Worth Venture Partners’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$271K	Buy	+17,250	New	+$221K	0.61%	29

Other funds holding CYRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Worth Venture Partners's CYRX Position: Q2 2026 in Review

Worth Venture Partners opened a new position in CryoPort (CYRX) in Q2 2026: 17,250 shares worth $271K. The stake represents 0.61% of the portfolio and ranks #29 among its holdings.

185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

Worth Venture Partners held 17,250 shares of CryoPort worth $271K as of Q2 2026.
CryoPort was a new Worth Venture Partners position in Q2 2026.
CryoPort made up 0.61% of Worth Venture Partners's portfolio in Q2 2026, its #29 holding.
185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Worth Venture Partners's 13F filing for Q2 2026, filed 10 Aug 2026.